Mitoxantrone Dihydrochloride is an anthracycline chemotherapeutic agent used to treat conditions such as secondary progressive multiple sclerosis and hematologic malignancies like acute myeloid leukemia.… Read more
Mitoxantrone Dihydrochloride is an anthracycline chemotherapeutic agent used to treat conditions such as secondary progressive multiple sclerosis and hematologic malignancies like acute myeloid leukemia. By intercalating into DNA and inhibiting topoisomerase II, the drug effectively disrupts the division of cancer cells. This category provides essential reference standards for Mitoxantrone Dihydrochloride, including its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these high-quality materials for critical analytical testing, impurity profiling, and method validation throughout the drug development lifecycle. Accessing reliable standards ensures accurate identification and quantification of related substances, supporting strict quality control protocols for both finished pharmaceutical products and active pharmaceutical ingredients. These compounds facilitate rigorous compliance with regulatory requirements during stability studies and routine analysis of this potent antineoplastic medication.